Hidradenitis suppurativa - The therapeutic possibilities - Case report;Hidradenitis suppurativa - Możliwości terapeutyczne - Opis przypadku

Postepy Dermatologii i Alergologii

Volumn 25, Issue 3, 2008, Pages 138-142

  Szulczyńska Gabor, Joanna ^a   Fuksieweicz, Wieslawa ^a   Emerie, Atena ^a   Głośnicka, Marzena ^a   Bowszczyc Dmochowska, Monika ^a   Zaba, Ryszard ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Acne inversa; Biological drugs; Hidradenitis suppurativa; Therapy

Indexed keywords

CETIRIZINE; CIPROFLOXACIN; CLEMASTINE; COTRIMOXAZOLE; DEXAMETHASONE; DOXYCYCLINE; METRONIDAZOLE; PARACETAMOL; TRAMADOL;

ADULT; ARTICLE; BACTEROIDES FRAGILIS; CASE REPORT; CLINICAL PROTOCOL; ERYTHROCYTE COUNT; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; LEUKOCYTE COUNT; MALE; NONHUMAN; SUPPURATIVE HIDRADENITIS;

EID: 56149106890     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. De Vivier A. Atlas dermatologii klinicznej. Majewski S (red. wyd. pol.) Urban & Partner, Wroclaw 2005; 614-6.
2. Jabłońska S, Majewski S. Choroby skóry i choroby przenoszone droga płciowa. Wydawnictwo PZWL 2005; 44-5.
3. Jemec GB. Medical treatment of hidradenitis suppurativa. Expert Opin Pharmacother 2004; 5: 1767-70.
4. Braun-Falco O, Plewik G, Wolff H i wsp. Dermatolgia. Tom II. Czelej, Lublin 2002; 1003-5.
5. Mortimer PS, Lunniss PJ. Hidradenitis suppurativa. J R Soc Med 2000; 93: 420-2.
6. Shah N. Hidradenitis suppurativa: a treatment challenge. Am Fam Physician 2005; 72: 1547-52.
7. Thielen AM, Barde C, Saurat JH. Long-term infliximab for severe hidradenitis suppurativa. Br J Dermatol 2006; 155: 1105-7.
8. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001; 144: 809-13.
9. Bazex J, Bayle P, San B. Hidradenitis suppurativa is acne inversa. Int J Dermatol 2007; 46: 330.
10. Sellheyer K, Krahl D. "Hidradenitis suppurativa" is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol 2005; 44: 535-40.
11. von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2000; 14: 389-92.
12. Revuz J. Hidradenitis suppurativa. Orphanet Encyclopedia. March 2004.
13. von der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol 2000; 142: 947-53.
14. Fitzsimmons JS, Fitzsimmons EM, Gilbert G. Familial hidradenitis suppurativa: evidence in favour of single gene transmission. J Med Genet 1984; 21: 281-5.
15. Dmochowski M, Prokop J. Severe acne vulgaris in patient with Apert's syndrome-like changes. Post Dermatol 1989; 6: 477-90.
16. Lapins J, Ye W, Nyrén O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol 2001; 137: 730-4.
17. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, el al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol 2007; 156: 51-6.
18. Adams DR, Gordon KB, Devenyi AG, Ioffreda MD. Severe hidradenitis suppurativa treated with infliximab infusion. Arch Dermatol 2003; 139: 1540-2.
19. Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, et al. An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br J Dermatol 2008; 158: 567-72.
20. Sullivan TP, Welsh E, Kerdel FA, et al. Infliximab for hidradenitis suppurativa. Br J Dermatol 2003; 149: 1046-9.
21. Mendonça CO, Griffiths CE. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 2006; 154: 977-8.
22. Moul DK, Korman NJ. The cutting edge. Severe hidradenitis suppurativa treated with adalimumab. Arch Dermatol 2006; 142: 1110-2.